Primary record
9,10-dimethoxy-2-(2,4,6-trimethylphenylimino)-3-(N-carbamoyl-2-aminoethyl)-3,4,6,7-tetrahydro-2H-pyrimidino(6,1-a)isoquinolin-4-one
- 库存
- 3,599 克
- 纯度
- 98.8 %
- CAS
- 1884461-72-6
化合物标识与属性
- CAS
- 1884461-72-6
- PubChem CID
- 9934746
- SMILES
- CC1=CC(=C(C(=C1)C)N=C2C=C3C4=CC(=C(C=C4CCN3C(=O)N2CCNC(=O)N)OC)OC)C
- Canonical SMILES
- COc1cc2c(cc1OC)-c1cc(=Nc3c(C)cc(C)cc3C)n(CCNC(N)=O)c(=O)n1CC2
名称与同义词
- Ensifentrine
- RPL-554
- Ensifentrina
- Ohtuvayre
- Ensifentrine?
- RPL554
- (E/Z)-Ensifentrine
- Ensifentrine [INN]
- (E)-Ensifentrine
- Ohtuvayre (TN)
- Ensifentrine [USAN]
- 1884461-72-6
- 298680-25-8
- UNII-3E3D8T1GIX
- RPL-554;Ensifentrinum
- RefChem:360374
- 3E3D8T1GIX
- Ensifentrine (USAN/INN)
- Ensifentrine [USAN:INN]
- D08VHG
- RPL 554
- VMX-554
- ENSIFENTRINE [WHO-DD]
- SCHEMBL625876
- SCHEMBL626531
- LS-193855
- orb1305343
- orb1739989
- VMX554
- CHEMBL4594287
- SCHEMBL20720900
- SCHEMBL29415734
- SCHEMBL30954264
- SCHEMBL30954265
- a]isoquinolin-3(4H)-yl}ethyl)urea
- GTPL11865
- DTXSID00183983
- RPL-565
- VMX 554
- VMX-565
- YQF2527
- CSOBIBXVIYAXFM-UHFFFAOYSA-N
- GLXC-23096
- BCP31840
- EX-A6633
- JAD46172
- MFCD09970918
- WHO 10726
- LS-193,855
- AKOS040746804
- AT44223
- AT46895
- CID9934746
- SB19810
- CID 9934746
- EBC-2563075
- PDE 3/PDE 4 inhibitors, Kings College
- AC-38438
- DA-52919
- DA-77550
- MS-28860
- SY295045
- HY-111477
- CS-0041580
- 2-[9,10-dimethoxy-4-oxo-2-(2,4,6-trimethylphenyl)imino-6,7-dihydropyrimido[6,1-a]isoquinolin-3-yl]ethylurea
- J3.799.901F
- D11743
- trimethylphenyl)imino]-6,7-dihydro-2H-pyrimido[6,1-
- N-(2-{(2E)-9,10-dimethoxy-4-oxo-2-[(2,4,6-
- Q7277486
- (E)-1-(2-(2-(mesitylimino)-9,10-dimethoxy-4-oxo-6,7-dihydro-2H-pyrimido[6,1-a]isoquinolin-3(4H)-yl)ethyl)urea
- Ensifentrina; Ensifentrinum;RPL-554;RPL554;RPL 554
- PDE3/4 inhibitors (respiratory therapeutics), Rhinopharma
- 1-(2-(2-(Mesitylimino)-9,10-dimethoxy-4-oxo-6,7-dihydro-2H-pyrimido[6,1-a]isoquinolin-3(4H)-yl)ethyl)urea
- N-[2-[6,7-Dihydro-9,10-dimethoxy-4-oxo-2-[(2,4,6-trimethylphenyl)imino]-2H-pyrimido[6,1-a]isoquinolin-3(4H)-yl]ethyl]urea
- PDE3/4 inhibitors (nasal, respiratory disease), Verona Pharma
- (2-{9,10-dimethoxy-4-oxo-2-[(2,4,6-trimethylphenyl)imino]-2H,3H,4H,6H,7H-pyrimido[4,3-a]isoquinolin-3-yl}ethyl)urea
- 2-(9,10-Dimethoxy-4-oxo-2-(2,4,6-trimethylphenyl)imino-6,7-dihydropyrimido(6,1-a)isoquinolin-3-yl)ethylurea
- 9,10-dimethoxy-2-(2,4,6-trimethylphenylimino)-3-(N-carbamoyl-2-aminoethyl)-3,4,6,7-tetrahydro-2H-pyrimidino(6,1-a)isoquinolin-4-one
- N-(2-((2E)-9,10-Dimetoxi-4-oxo-2-((2,4,6-trimetilfenil)imino)-6,7-dihidro-2H-pirimido(6,1-a)isoquinolein-3(4H)-il)etil)urea
- Urea, N-(2-(6,7-dihydro-9,10-dimethoxy-4-oxo-2-((2,4,6-trimethylphenyl)imino)-2H-pyrimido(6,1-a)isoquinolin-3(4H)-yl)ethyl)-
- Trequinsin analogs (respiratory therapeutics), Kings College/Vernalis/Rhinopharma
- (E)-1-[2-[2-(Mesitylimino)-9,10-dimethoxy-4-oxo-6,7-dihydro-2H-pyrimido[6,1-a]isoquinolin-3(4H)-yl]ethyl]urea
- [2-[6,7-Dihydro-9,10-dimethoxy-4-oxo-2-[(2,4,6-trimethylphenyl)imino]-2H-pyrimido[6,1-a]isoquinolin-3(4H)-yl]ethyl]-urea
- {2-[(2E)-9,10-dimethoxy-4-oxo-2-[(2,4,6-trimethylphenyl)imino]-2H,3H,4H,6H,7H-pyrimido[4,3-a]isoquinolin-3-yl]ethyl}urea
- 9,10-Dimethoxy-2-(2,4,6-trimethylphenylimino)-3-(N-carbamoyl-2-aminoethyl)-3,4,6,7-tetrahydro-2H-pyrimido[6,1-a]isoquinolin-4-one
- 9,10-Dimethoxy-2-(2,4,6-trimethylphenylimino)3-(N-carbamoyl-2-aminoethyl)-3,4,6,7-tetrahydro-2H-pyrimido[6,1-a]isoquinolin-4-one
- 9,10-Dimethoxy-2-(2.4.6-trimethylphenylimino)-3-(N-carbamoyl-2-aminoethyl)-3,4,6,7-tetrahydro-2H-pyrimido[6.1-a]isoquinolin-4-one
- N-(2-(6,7-Dihydro-9,10-dimethoxy-4-oxo-2-((2,4,6-trimethylphenyl)imino)-2H-pyrimido(6,1-a)isoquinolin-3(4H)-yl)ethyl)urea
- N/A